CDAKB Operational Rules Indonesia Under Permenkes 5/2026

CDAKB Operational Rules Indonesia Under Permenkes 5/2026 | INSIGHTOF

CDAKB operational rules Indonesia now sit under two overlapping regulations: Ministry of Health Regulation (Permenkes) No. 5 of 2026, effective May 4, 2026, and Permenkes No. 11 of 2025. Although CDAKB was renamed CDB for Medical Devices in 2025, Article 125(v) of Permenkes 5/2026 preserved Article 2 and the 13-clause Technical Appendix of Permenkes 4/2014. Medical device distributors and foreign brands face strict warehouse, outsourcing, reporting, and sanction rules that go well beyond getting the initial certificate.

May 4, 2026
Effective date of Permenkes No. 5/2026 on Health Supplies (BNRI 2026 No. 283)
May 4, 2027
One-year transition deadline to align distribution operations under Article 122
IDR 3,000,000
Upfront PNBP certification fee paid before submitting evaluation documents

1. How Permenkes 5/2026 Reshaped CDAKB Operational Rules Indonesia

On April 17, 2026, Indonesia’s Ministry of Health (Kemenkes) enacted Permenkes No. 5 of 2026 on Health Supplies (Perbekalan Kesehatan). The decree took effect on May 4, 2026. It consolidates supply-chain rules across pharmaceuticals, medical devices, and household health supplies (PKRT) under Government Regulation (PP) No. 28 of 2024.

Many distributors assumed Permenkes 5/2026 erased Permenkes No. 4 of 2014 on Good Distribution Practice for Medical Devices (CDAKB). In fact, Article 125(v) revoked Permenkes 4/2014 except Article 2 and its Technical Appendix.

Article 64(5) of Permenkes 5/2026 states that medical device distribution must follow CDB standards set by the Minister. Kemenkes has not yet issued a standalone replacement technical manual under that article. Until it does, the 13 technical clauses in the Permenkes 4/2014 Appendix stay legally binding. Under Article 122 of Permenkes 5/2026, businesses have until May 4, 2027, to align all operational arrangements.

Two-Layer Compliance Structure: Permenkes No. 11 of 2025 governs how you apply for, amend, verify, and renew your CDB Certificate in OSS. Permenkes 5/2026 and the surviving Permenkes 4/2014 Appendix govern daily warehouse, vendor, reporting, and vigilance compliance.

2. The 3PL Storage Ban and Outsourcing Boundaries

Foreign manufacturers entering Indonesia often ask if a licensed distributor can store inventory in a third-party logistics (3PL) warehouse. Under Clause 13.d of the surviving Permenkes 4/2014 Appendix, the answer is no. A medical device distributor (PAK) or branch may delegate activities to third parties as needed, except storage activities (kecuali kegiatan penyimpanan).

You cannot outsource medical device warehousing to a generic 3PL provider. Every distributor and branch must control its own registered storage premises listed on its IDAK distribution permit and CDAKB/CDB certificate.

Other operational tasks can be contracted to third parties if you meet three conditions under Clause 13.a through 13.c:

  • Contracted work requires a written agreement defining regulatory duties and quality controls.
  • Your company must specify and monitor the exact type of control exercised over the vendor.
  • Every outsourced activity must sit inside your distributor’s internal and regulatory facility audit scope.

Permissible outsourced functions include freight and cold-chain transport, instrument calibration, and pest control. Authorized after-sales workshop services (Clause 3.a.14) and licensed hazardous waste destruction (Permenkes 5/2026, Article 90(4)) may also be contracted out.

3PL Warning for Foreign Entrants: Some prospective Indonesian partners propose holding imported stock inside an unregistered 3PL warehouse while using their office address on paper. That setup violates Clause 13.d and fails Kemenkes field verification.

3. Warehouse, Calibration, and Cold-Chain Audit Checks

Document checklists show what files to upload, but Kemenkes inspectors verify floor-level controls during physical or virtual site visits. Several quantitative requirements in Clauses 1, 3, and 4 of the surviving Permenkes 4/2014 Appendix catch distributors off guard.

Operational AreaMandatory StandardRegulatory Clause
Warehouse forkliftsElectric or battery equipment allowed; petrol, diesel, and gas forklifts banned indoorsClause 3.a.11 to 3.a.12
Instrument calibrationThermohygrometers calibrated against traceable national or international standardsClause 4.c.1 and 4.d.1.l
Temperature loggingControlled rooms logged for daily min and max temperatures at least twice per dayClause 4.d.1.i
Humidity control“Protect from moisture” items kept at 60% relative humidity or lower in normal storageClause 4.d.1.j
Sensor placementSensors placed in the most fluctuating spots, such as near exit and loading doorsClause 4.d.1.k
Cold-chain shippingNo direct dry-ice contact with products; delivery trucks never used as storageClause 4.e.5 to 4.e.6
Electromedical and IVDCompetent technician plus owned or contracted workshop and installation test logsClause 1.a.4, 3.a.14, 4.f

For Korean, European, and Japanese brands exporting aesthetic lasers, dental imaging units, or in vitro diagnostic (IVD) analyzers, Clauses 3.a.14 and 4.f matter immediately. Your distributor cannot simply drop devices at a clinic door.

Distributors of electromedical devices and IVD products must employ competent technicians under Clause 1.a.4. They must also maintain a workshop facility, either in-house or via formal contract with an authorized workshop, under Clause 3.a.14. Under Clause 4.f, the distributor must establish installation qualification procedures, test installed units against factory manuals, and keep signed test records.

4. Authorized Buyers, Vigilance, and Implant Traceability

Permenkes 5/2026 also tightens downstream buyer limits, post-market vigilance, and supply reporting for medical device distributors.

Article 72(1) limits who a manufacturer, distributor, or branch may legally supply. Approved buyers include medical device manufacturers, pharmaceutical industries, licensed medical device distributors or branches, healthcare facilities, government pharmaceutical units, pharmacy facilities, and research institutions. Household-equipment wholesalers and retailers can receive only specific device categories designated by the Minister.

For high-risk implants, Clauses 5.c and 5.d of the surviving Technical Appendix require patient-level traceability. This applies to mechanical heart valves, implantable pacemakers, implantable defibrillators, cardiac stents, ventricular assist systems, and implantable drug-infusion systems. Where patient tracking is impossible, traceability must reach the user healthcare facility and log both implantation and explantation dates. Under Clauses 1.b.11 and 5.b, records must stay archived for the device’s lifetime, and never less than 2 years from dispatch.

Permenkes 5/2026 also locks in four statutory reporting and disposal duties tied to Indonesia’s National Health Information System (SIKN):

Under Article 81, distributors using electronic systems must submit distribution activity reports through SIKN-integrated portals such as E-Report. Before destroying expired, defective, or revoked stock, Article 91 requires a formal risk analysis covering misuse potential and environmental or human safety impacts.

Under Article 96(1)(c), marketing authorization (NIE) holders must report any expected supply shortage to Kemenkes at least 6 months in advance. Articles 103(2) and 104 require NIE holders to monitor and report medical device safety incidents (vigilans) within Ministry deadlines.

5. Coordinate Changes, PNBP, and Annual Internal Audits

Under Permenkes 11/2025 (Annex pages 443 to 451) and notices on the Kemenkes Seralkes portal, keeping a CDB Certificate valid depends on four procedural triggers.

Warehouse changes depend on geographic coordinates. Under Permenkes 11/2025, an address change that alters your warehouse’s coordinates requires applying for a brand-new CDB Certificate rather than filing an amendment. Adding a warehouse, moving a warehouse, or changing device product groups triggers field verification. Editing an address or workshop name without moving location, or removing a warehouse, requires document verification only.

Post-Certificate Compliance and Renewal Checklist

  • Upfront PNBP payment: Since September 1, 2025, distributors must pay the IDR 3,000,000 CDB fee (PNBP) before submitting application files in Seralkes.
  • Annual internal audits: Central distributors submit annual internal audit reports to Kemenkes, and branches report to provincial authorities. Kemenkes reinforced this duty at its April 2, 2026 workshop and October 27, 2026 CDB assistance desk.
  • Activation deadlines: Distributors must start procuring and distributing certified device groups within 12 months of first issuance, or within 6 months after renewal.
  • Six-month renewal window: Submit renewal packages at least 6 months before expiry, attaching an internal audit report from the current or prior year.

Track deficiency clocks closely during OSS and Seralkes reviews. Permenkes 11/2025 allows up to 2 document correction rounds of 10 days each and 2 field CAPA rounds of 30 days each. Kemenkes froze those clocks twice in 2026: June 15 to 19 under Announcement HK.02.03/E.VI/3430/2026 for the KBLI 2025 rollout, and July 1 to 8 under Announcement HK.02.03/E.VI/3769/2026 for OSS-Seralkes integration issues. Checking Seralkes announcements regularly prevents accidental application expiry.

6. Administrative Sanctions and Blacklist Risks

Previously, many distributors viewed CDAKB gaps mainly as a delay to new product registration. Article 117 of Permenkes 5/2026 attaches explicit statutory sanctions to distributing devices outside CDB compliance (Article 64(3)) and skipping electronic distribution reports (Article 81).

Under Article 117(2) through (4), Kemenkes can escalate from written warnings to license freezes, administrative fines, coercive police measures (daya paksa polisional), and full license revocation. Coercive measures include forced recalls, compensation orders, product destruction, blocking electronic systems, blocking licensing portal access, and blacklisting from licensing and public procurement.

Hospital tenders and Indonesia’s sectoral e-Catalogue already require valid CDB status. A portal block or procurement blacklist halts revenue across every registered SKU at once. Keeping your IDAK distribution permit, warehouse controls, and E-Report filings aligned prevents those triggers.

7. Practical Action Steps Before May 4, 2027

If you already hold a CDB or legacy CDAKB certificate, start preparing early. The same applies if you are vetting a local partner before signing a Letter of Authorization. Run four operational checks ahead of the May 4, 2027 adjustment deadline.

1
Audit third-party warehouse and logistics contracts
Confirm all stock sits inside the distributor’s own licensed warehouse, never in a 3PL facility. Verify written quality contracts for transport, calibration, and pest vendors inside your audit scope.
2
Verify warehouse equipment and twice-daily temperature logs
Check that indoor forklifts run on electric or battery power and thermohygrometers hold current traceable calibration certificates. Confirm doorway sensors and twice-daily min-max temperature logs are active.
3
Confirm electromedical or IVD workshop and installation files
If you sell powered devices or IVD analyzers, verify technician credentials and owned or contracted workshop agreements. Archive signed installation qualification and test records for each unit.
4
Schedule annual internal audits and coordinate checks
Calendar your annual internal audit report to Kemenkes and update E-Report and vigilance SOPs for Permenkes 5/2026. Check whether any planned warehouse move changes coordinates enough to require a new CDB application.

8. Frequently Asked Questions

Q: Is Permenkes 4/2014 on CDAKB still valid after Permenkes 5/2026?
A: Partially. Article 125(v) of Permenkes 5/2026 revoked Permenkes 4/2014 except Article 2 and its 13-clause Technical Appendix, which remain the active technical baseline until Kemenkes issues a replacement guideline under Article 64(5).
Q: Can a medical device distributor outsource warehousing to a 3PL company in Indonesia?
A: No. Clause 13.d of the surviving Permenkes 4/2014 Appendix allows outsourcing support activities as needed except storage. A distributor or branch must control its own registered storage facility.
Q: Do we need a new CDB certificate if our medical device warehouse moves to a new address?
A: Yes, if the move changes your warehouse’s geographic coordinates. Under Permenkes 11/2025, coordinate changes require applying for a new CDB Certificate rather than submitting a technical attachment amendment.
Q: What are the penalties for violating CDAKB or CDB rules under Permenkes 5/2026?
A: Article 117 of Permenkes 5/2026 authorizes written warnings, temporary license freezes, administrative fines, license revocation, blocking of electronic systems and licensing portals, and blacklisting from licensing and procurement.

Need Help Passing CDB Audits or Auditing Your Indonesian Distributor?

INSIGHTOF Consulting Indonesia helps foreign manufacturers and local distributors align warehouse SOPs, workshop contracts, and Permenkes 5/2026 reporting before Kemenkes inspections. Established 2016, 1,000+ BPOM & halal filings.

INSIGHTOF Consulting Indonesia

Established 2016 | 1,000+ BPOM & Halal Filings

📧 marketing@insightof.co.id

📱 +62 897 647 0070 (WhatsApp)

🌐 Fixed Pricing & On-Time Guarantee Details

Get the Right Regulatory Support

We help local and international businesses meet Indonesian regulatory requirements in a structured, compliant, and reliable manner.